<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/59F09DF9-DD13-4FFB-9429-2993C1DD4F54"><gtr:id>59F09DF9-DD13-4FFB-9429-2993C1DD4F54</gtr:id><gtr:name>MRC Human Reproductive Sciences Unit</gtr:name><gtr:address><gtr:line1>Centre for Reproductive Biology</gtr:line1><gtr:line2>37 Chalmers Street</gtr:line2><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH3 9EW</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/59F09DF9-DD13-4FFB-9429-2993C1DD4F54"><gtr:id>59F09DF9-DD13-4FFB-9429-2993C1DD4F54</gtr:id><gtr:name>MRC Human Reproductive Sciences Unit</gtr:name><gtr:address><gtr:line1>Centre for Reproductive Biology</gtr:line1><gtr:line2>37 Chalmers Street</gtr:line2><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH3 9EW</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/A0CBAAE6-12FF-4EE2-A774-DB55503C36F6"><gtr:id>A0CBAAE6-12FF-4EE2-A774-DB55503C36F6</gtr:id><gtr:firstName>RP</gtr:firstName><gtr:surname>Millar</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=MC_U127681325"><gtr:id>E09C5F3B-3CF5-46D5-9201-38EF1B005B7E</gtr:id><gtr:title>Development and application of ligand-selective-signalling GnRH analogues</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Intramural</gtr:grantCategory><gtr:grantReference>MC_U127681325</gtr:grantReference><gtr:abstractText>A hormone produced in minute quantities in the base of the brain is responsible for controlling all of reproduction. It is called Gonadotropin-Releasing Hormone (GnRH) and stimulates pituitary reproductive hormones which in turn stimulate sperm and egg, and sex hormone production by the testes and ovaries. As a result of this pivotal role GnRH stimulatory and inhibitory analogues are extensively used to treat reproductive diseases (e.g. infertility, prostatic and breast cancer and endometriosis, $1.5 billion annual sales). Our fundamental research on the molecular functioning of the GnRH receptor has revealed how GnRH analogues work and will continue to discover new GnRH analogues that are more refined in their actions. These new analogues with far wider and more specific application in disease, will be beneficial in developing new contraceptives with fewer side-effects for men and women. They may also identify new therapeutic approaches in the fight against hormone dependent diseases and cancers.</gtr:abstractText><gtr:technicalSummary>GnRH analogues exhibit distinctly different pharmacology in inhibiting tumour cell proliferation compared with effects on the pituitary gonadotrope. These differences suggested a novel (type II) GnRH receptor was involved. We cloned a type II receptor in the marmoset but found the human homologue could not be translated into a functional receptor. We then demonstrated that the different pharmacology at the gonadotrope and tumour cells could be mediated through the same type I receptor and was effected through differing intracellular environments and could be directed by ligand structural differences. The studies on the molecular functioning of the GnRH receptor (C1) and identification of the diverse signalling which can be elicited by conformers of specific ligand-receptor complexes (C2) sets the scene for the development of new signal-specific GnRH analogues in this programme. Based on the relative activities of GnRH I and GnRH II a series of analogues with single and dual amino acid substitution were studied. The greatest preferential cell antiproliferatial action is conveyed by Trp7, Tyr8 substitution in GnRH I. A further series of agonist analogues have been designed and tested based on these findings. Screening of relative signalling activities of 12 antagonist analogues revealed that 1-MelPal in position five and D-IPrLys in position six yielded increased G i activity. A further series of antagonists are being screened and others synthesised based on the structure/activity results. Since the structure/activity data derived from primary sequence can be cryptic we will also undertake studies on the 3D structures of selected analogues using molecular modelling and low energy mass spectrometry fragmentation. We have now tested analogs in vivo and show potent and complete inhibition of tumour growth in nude mice. Our recent identification of novel GnRH signalling pathways (C2) will allow testing of selected analogues for activation/inhibition of these novel pathways in addition to the classical G q pathway. Ligand-selective signalling analogues will also be used to probe the effects on cellular function of pituitary gonadotropes, as well as uterine, ovarian and prostate cells. Although widely used, there is scope for improvement in specificity, duration of action and oral bioavailability of GnRH analogues. We have shown that conjugation of steroid hormones to position six of GnRH analogues conveys plasma protein binding capacity and increases half-life and duration of action. These conjugates maintain high receptor binding affinity and inhibition (antagonists) or activation (agonists) of intracellular signalling. Moreover, conjugation to appropriate steroid carbon atoms allows maintenance of full steroid biological activity. Our main studies have concentrated on progesterone conjugation to a series of GnRH antagonists. One of these potently inhibited testosterone in male marmosets with an increased duration of action. We propose to now produce GnRH antagonist testosterone conjugates as a single male hormonal contraceptive which will suppress gonadotropins and spermatogenesis while also supplying androgen replacement. By conjugating antagonist to the prostate-sparing androgen (MENT) we propose to produce a bifunctional analogue for contraception and for potential application in prostate disease. The possibility of conveying oral bioavailability to these conjugates will also be explored by piggy-backing the conjugates on molecules actively absorbed in the gut such as vitamin B12.</gtr:technicalSummary><gtr:fund><gtr:end>2011-03-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2005-04-01</gtr:start><gtr:type>EXPENDITURE_ACTUAL</gtr:type><gtr:valuePounds>3434230</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>EB388112-FC01-458B-83C8-7300228A2DBE</gtr:id><gtr:title>Reciprocal cross talk between gonadotropin-releasing hormone (GnRH) and prostaglandin receptors regulates GnRH receptor expression and differential gonadotropin secretion.</gtr:title><gtr:parentPublicationTitle>Molecular endocrinology (Baltimore, Md.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ffe7a2d34916a6fc5789de16c4c3a085"><gtr:id>ffe7a2d34916a6fc5789de16c4c3a085</gtr:id><gtr:otherNames>Naor Z</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0888-8809</gtr:issn><gtr:outcomeId>49C5A93E765</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>32B8D9FB-89C1-4CD0-929F-3F3EAE6BFFF4</gtr:id><gtr:title>The chicken type III GnRH receptor homologue is predominantly expressed in the pituitary, and exhibits similar ligand selectivity to the type I receptor.</gtr:title><gtr:parentPublicationTitle>The Journal of endocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/37e1cc6b04bd072bbea21e4749a26aa0"><gtr:id>37e1cc6b04bd072bbea21e4749a26aa0</gtr:id><gtr:otherNames>Joseph NT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0022-0795</gtr:issn><gtr:outcomeId>C2B83263491</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CBAA801F-5A16-423E-A308-5D5D2E213A20</gtr:id><gtr:title>Retention and silencing of prepro-GnRH-II and type II GnRH receptor genes in mammals.</gtr:title><gtr:parentPublicationTitle>Neuroendocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/60fe7763581fe9d8ccb7b6d64afc8242"><gtr:id>60fe7763581fe9d8ccb7b6d64afc8242</gtr:id><gtr:otherNames>Stewart AJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0028-3835</gtr:issn><gtr:outcomeId>B4ABF22EE9E</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>06716A9B-9B4F-4F3B-878B-B01DAC830BF9</gtr:id><gtr:title>Diversity of actions of GnRHs mediated by ligand-induced selective signaling.</gtr:title><gtr:parentPublicationTitle>Frontiers in neuroendocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d30c01de2bf5e02d1364c0fd0e2ba03d"><gtr:id>d30c01de2bf5e02d1364c0fd0e2ba03d</gtr:id><gtr:otherNames>Millar RP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0091-3022</gtr:issn><gtr:outcomeId>450D85E4A6E</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E8104DE3-7573-4CBA-A2EC-DD9E47EC80B4</gtr:id><gtr:title>Activation of mitogen-activated protein kinase (MAPK) by GnRH is cell-context dependent.</gtr:title><gtr:parentPublicationTitle>Molecular and cellular endocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/db0dc19bc198d1424f6f651faec60231"><gtr:id>db0dc19bc198d1424f6f651faec60231</gtr:id><gtr:otherNames>Dobkin-Bekman M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0303-7207</gtr:issn><gtr:outcomeId>7B977B135D9</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BFEE7CF1-9F10-49EC-BDB5-007BCEC2F1F5</gtr:id><gtr:title>A crucial role for Galphaq/11, but not Galphai/o or Galphas, in gonadotropin-releasing hormone receptor-mediated cell growth inhibition.</gtr:title><gtr:parentPublicationTitle>Molecular endocrinology (Baltimore, Md.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0254dbc190faccb715829795816143ac"><gtr:id>0254dbc190faccb715829795816143ac</gtr:id><gtr:otherNames>White CD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0888-8809</gtr:issn><gtr:outcomeId>A42FCA6BD04</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>99D5C5A9-ADEB-4EAF-A91E-33486C677D01</gtr:id><gtr:title>Hypothalamic pro-GnRH-GAP, GnRH-I and GnRH-II during the onset of photorefractoriness in the white-crowned sparrow (Zonotrichia leucophrys gambelii).</gtr:title><gtr:parentPublicationTitle>Journal of neuroendocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/62d86ccdcdb17e6a72467145e3674ec6"><gtr:id>62d86ccdcdb17e6a72467145e3674ec6</gtr:id><gtr:otherNames>Meddle SL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0953-8194</gtr:issn><gtr:outcomeId>C5A8E148AA9</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>04580858-3A45-4330-BB47-9389051972DD</gtr:id><gtr:title>Gonadotropin-releasing hormone analog structural determinants of selectivity for inhibition of cell growth: support for the concept of ligand-induced selective signaling.</gtr:title><gtr:parentPublicationTitle>Molecular endocrinology (Baltimore, Md.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cac938ec0dd9ea375263180f8739772e"><gtr:id>cac938ec0dd9ea375263180f8739772e</gtr:id><gtr:otherNames>L?pez de Maturana R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0888-8809</gtr:issn><gtr:outcomeId>B8FCA352D90</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>729D7C48-A71E-4E68-94FF-397D00F03647</gtr:id><gtr:title>Molecular genetic analysis of normosmic hypogonadotropic hypogonadism in a Turkish population: identification and detailed functional characterization of a novel mutation in the gonadotropin-releasing hormone receptor gene.</gtr:title><gtr:parentPublicationTitle>Neuroendocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a06d8982d1e7fa6e2a027a7997920648"><gtr:id>a06d8982d1e7fa6e2a027a7997920648</gtr:id><gtr:otherNames>Topaloglu AK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0028-3835</gtr:issn><gtr:outcomeId>2ACCD9F4A88</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7082BF8C-860A-4EC1-AA31-CB754AED8D63</gtr:id><gtr:title>Gonadotropin-releasing hormone functionally antagonizes testosterone activation of the human androgen receptor in prostate cells through focal adhesion complexes involving Hic-5.</gtr:title><gtr:parentPublicationTitle>Neuroendocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/65317169098fb4f762fa4cfb0aa03048"><gtr:id>65317169098fb4f762fa4cfb0aa03048</gtr:id><gtr:otherNames>Maudsley S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0028-3835</gtr:issn><gtr:outcomeId>D23EE958759</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5AEC830D-8EFC-43D9-AAEF-9056E13E6304</gtr:id><gtr:title>Structural determinants for ligand-receptor conformational selection in a peptide G protein-coupled receptor.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/84cbccc188f0530d95a8967a68afd913"><gtr:id>84cbccc188f0530d95a8967a68afd913</gtr:id><gtr:otherNames>Lu ZL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>69A11045596</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D2BCCC72-F8AD-4496-8360-69B9C01865D1</gtr:id><gtr:title>Isolated familial hypogonadotropic hypogonadism and a GNRH1 mutation.</gtr:title><gtr:parentPublicationTitle>The New England journal of medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/70c011d8d02fef55afb68eaba18d9378"><gtr:id>70c011d8d02fef55afb68eaba18d9378</gtr:id><gtr:otherNames>Bouligand J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0028-4793</gtr:issn><gtr:outcomeId>120063F1724</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CCC43DA2-EB6C-4DAC-B7DB-5415EB759403</gtr:id><gtr:title>Gene structure and promoter functional analysis of the marmoset type II GnRH receptor.</gtr:title><gtr:parentPublicationTitle>Journal of molecular endocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3a04fb05e8063b7201f2149c47606188"><gtr:id>3a04fb05e8063b7201f2149c47606188</gtr:id><gtr:otherNames>Faurholm B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0952-5041</gtr:issn><gtr:outcomeId>45D3A5F9A8C</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>170AEAC0-1CF1-4BF7-81AB-7EAA05E5AAD3</gtr:id><gtr:title>Gonadotropin-releasing hormone II stimulates female sexual behavior in marmoset monkeys.</gtr:title><gtr:parentPublicationTitle>Endocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0124b567999aa3595c057935c64b763b"><gtr:id>0124b567999aa3595c057935c64b763b</gtr:id><gtr:otherNames>Barnett DK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0013-7227</gtr:issn><gtr:outcomeId>03FE0F5DD85</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>745B6F28-534D-4EB2-9D19-824E40F85AD3</gtr:id><gtr:title>Nuclear stabilization of beta-catenin and inactivation of glycogen synthase kinase-3beta by gonadotropin-releasing hormone: targeting Wnt signaling in the pituitary gonadotrope.</gtr:title><gtr:parentPublicationTitle>Molecular endocrinology (Baltimore, Md.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/617474bae56983ec0f4cc48b6fd0141c"><gtr:id>617474bae56983ec0f4cc48b6fd0141c</gtr:id><gtr:otherNames>Gardner S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0888-8809</gtr:issn><gtr:outcomeId>A2907315F9B</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D3A1E310-FD7D-4E93-B892-8C6BB7C00410</gtr:id><gtr:title>Photoperiod-independent hypothalamic regulation of luteinizing hormone secretion in a free-living Sonoran desert bird, the Rufous-winged Sparrow (Aimophila carpalis).</gtr:title><gtr:parentPublicationTitle>Brain, behavior and evolution</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b37390f9a23f02dff4c7aa2e71614caa"><gtr:id>b37390f9a23f02dff4c7aa2e71614caa</gtr:id><gtr:otherNames>Small TW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0006-8977</gtr:issn><gtr:outcomeId>95FE9F96E42</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>ADB18C52-F9FB-4471-B19D-5BC5BCFC380F</gtr:id><gtr:title>Localization of the three GnRH types and GnRH receptors in the brain of a cichlid fish: Insights into their neuroendocrine and neuromodulator functions.</gtr:title><gtr:parentPublicationTitle>The Journal of comparative neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e35aec1e8f59e449349039975bef71ad"><gtr:id>e35aec1e8f59e449349039975bef71ad</gtr:id><gtr:otherNames>Soga T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>0021-9967</gtr:issn><gtr:outcomeId>4D5A3E27D3F</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>980A50B3-A092-4936-A386-4964B3A64815</gtr:id><gtr:title>Conserved amino acid residues that are important for ligand binding in the type I gonadotropin-releasing hormone (GnRH) receptor are required for high potency of GnRH II at the type II GnRH receptor.</gtr:title><gtr:parentPublicationTitle>Molecular endocrinology (Baltimore, Md.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c35d29813ef3fe887ee73fa46e41af64"><gtr:id>c35d29813ef3fe887ee73fa46e41af64</gtr:id><gtr:otherNames>Mamputha S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0888-8809</gtr:issn><gtr:outcomeId>0E89F6735A6</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C191F276-17E2-4236-9ABD-5CD576C260F3</gtr:id><gtr:title>Mammalian type I gonadotropin-releasing hormone receptors undergo slow, constitutive, agonist-independent internalization.</gtr:title><gtr:parentPublicationTitle>Endocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3a2b7dd178f2a3f4ada7a2b6f2289e04"><gtr:id>3a2b7dd178f2a3f4ada7a2b6f2289e04</gtr:id><gtr:otherNames>Pawson AJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0013-7227</gtr:issn><gtr:outcomeId>1F97C2E88AA</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A557B89B-2C26-4680-AD17-980A5FD88DDE</gtr:id><gtr:title>Identification of Tyr(290(6.58)) of the human gonadotropin-releasing hormone (GnRH) receptor as a contact residue for both GnRH I and GnRH II: importance for high-affinity binding and receptor activation.</gtr:title><gtr:parentPublicationTitle>Biochemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/72cc5081dc59a73d752576c51bbc909a"><gtr:id>72cc5081dc59a73d752576c51bbc909a</gtr:id><gtr:otherNames>Coetsee M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0006-2960</gtr:issn><gtr:outcomeId>609E0AF5E1F</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E2BC81A0-2FA9-4996-B6B3-FF2AC6D3D491</gtr:id><gtr:title>Proline-rich tyrosine kinase 2 mediates gonadotropin-releasing hormone signaling to a specific extracellularly regulated kinase-sensitive transcriptional locus in the luteinizing hormone beta-subunit gene.</gtr:title><gtr:parentPublicationTitle>Molecular endocrinology (Baltimore, Md.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/65317169098fb4f762fa4cfb0aa03048"><gtr:id>65317169098fb4f762fa4cfb0aa03048</gtr:id><gtr:otherNames>Maudsley S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0888-8809</gtr:issn><gtr:outcomeId>B8B1F5C82E6</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8210D1DF-22A8-45FA-B6B4-36B7B6DDB4C6</gtr:id><gtr:title>Potent action of RFamide-related peptide-3 on pituitary gonadotropes indicative of a hypophysiotropic role in the negative regulation of gonadotropin secretion.</gtr:title><gtr:parentPublicationTitle>Endocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/12651ed8a1aa38488fadea7b22ec6ea2"><gtr:id>12651ed8a1aa38488fadea7b22ec6ea2</gtr:id><gtr:otherNames>Clarke IJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0013-7227</gtr:issn><gtr:outcomeId>D7DC1D560C7</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>841A3DB4-750C-4E8F-8ED5-C941964CFF38</gtr:id><gtr:title>Changes to gonadotropin-releasing hormone (GnRH) receptor extracellular loops differentially affect GnRH analog binding and activation: evidence for distinct ligand-stabilized receptor conformations.</gtr:title><gtr:parentPublicationTitle>Endocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ac705829ac4887e0bbf7cfbb4dd6f967"><gtr:id>ac705829ac4887e0bbf7cfbb4dd6f967</gtr:id><gtr:otherNames>Pfleger KD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0013-7227</gtr:issn><gtr:outcomeId>D551AC6F877</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8B15785B-FEF5-4E91-B5F5-F7221EC6BD8A</gtr:id><gtr:title>Bifunctional gonadotropin-releasing hormone antagonist-progesterone analogs with increased efficacy and duration of action.</gtr:title><gtr:parentPublicationTitle>Endocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4c9af026ef0f22f5f673eb0f54ee2269"><gtr:id>4c9af026ef0f22f5f673eb0f54ee2269</gtr:id><gtr:otherNames>Ratcliffe KE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0013-7227</gtr:issn><gtr:outcomeId>A27D44C54CC</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3B37379F-41C8-4634-8729-A0DF571EDD19</gtr:id><gtr:title>Auditory stimulation of reproductive function in male Rufous-winged Sparrows, Aimophila carpalis.</gtr:title><gtr:parentPublicationTitle>Hormones and behavior</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b37390f9a23f02dff4c7aa2e71614caa"><gtr:id>b37390f9a23f02dff4c7aa2e71614caa</gtr:id><gtr:otherNames>Small TW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0018-506X</gtr:issn><gtr:outcomeId>78803BC440A</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>26F1F75D-26EB-4054-8BCD-EA28EA49BF52</gtr:id><gtr:title>Hypothalamic GnRH-I and its precursor during photorefractoriness onset in free-living male Dark-eyed Juncos (Junco hyemalis) of different year classes.</gtr:title><gtr:parentPublicationTitle>General and comparative endocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/62d86ccdcdb17e6a72467145e3674ec6"><gtr:id>62d86ccdcdb17e6a72467145e3674ec6</gtr:id><gtr:otherNames>Meddle SL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0016-6480</gtr:issn><gtr:outcomeId>31AE12FDDA0</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F660C248-E28E-40A5-9DFB-397463527E45</gtr:id><gtr:title>Protein kinase A serves as a primary pathway in activation of Nur77 expression by gonadotropin-releasing hormone in the LbetaT2 mouse pituitary gonadotroph tumor cell line.</gtr:title><gtr:parentPublicationTitle>International journal of oncology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3b91bd7137355f67908d3a1bd7e1c975"><gtr:id>3b91bd7137355f67908d3a1bd7e1c975</gtr:id><gtr:otherNames>Hamid T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1019-6439</gtr:issn><gtr:outcomeId>60319D4E087</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3A0C72B3-B1FB-4EEB-917A-39A531E36088</gtr:id><gtr:title>Phospholipase C-eta enzymes as putative protein kinase C and Ca2+ signalling components in neuronal and neuroendocrine tissues.</gtr:title><gtr:parentPublicationTitle>Neuroendocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/60fe7763581fe9d8ccb7b6d64afc8242"><gtr:id>60fe7763581fe9d8ccb7b6d64afc8242</gtr:id><gtr:otherNames>Stewart AJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0028-3835</gtr:issn><gtr:outcomeId>77827AB7759</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D3EE13A1-AE5B-4332-B77F-4451C9AD9FBF</gtr:id><gtr:title>Bovine and ovine gonadotropin-releasing hormone (GnRH)-II ligand precursors and type II GnRH receptor genes are functionally inactivated.</gtr:title><gtr:parentPublicationTitle>Endocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/de45de8bb44d401206ad3a7925ec7449"><gtr:id>de45de8bb44d401206ad3a7925ec7449</gtr:id><gtr:otherNames>Morgan K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0013-7227</gtr:issn><gtr:outcomeId>24947B2EA88</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AC0A6E27-44EA-4B2D-8457-AF90DFD90F59</gtr:id><gtr:title>Prokineticin 1 modulates IL-8 expression via the calcineurin/NFAT signaling pathway.</gtr:title><gtr:parentPublicationTitle>Biochimica et biophysica acta</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/94335aa40ba3df2a38b38cee8bab482a"><gtr:id>94335aa40ba3df2a38b38cee8bab482a</gtr:id><gtr:otherNames>Maldonado-P?rez D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0006-3002</gtr:issn><gtr:outcomeId>88EEFF64432</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C8998487-6378-4EB3-A08C-880F6DE16EC6</gtr:id><gtr:title>GnRH receptor expression in human prostate cancer cells is affected by hormones and growth factors.</gtr:title><gtr:parentPublicationTitle>Endocrine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6a680fcddbdde875b9eb195359cc07bb"><gtr:id>6a680fcddbdde875b9eb195359cc07bb</gtr:id><gtr:otherNames>Angelucci C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1355-008X</gtr:issn><gtr:outcomeId>8F9471E36AA</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E8124BA4-5F44-446D-9622-D2EACB0284E6</gtr:id><gtr:title>Identification of a novel ligand binding residue Arg38(1.35) in the human gonadotropin-releasing hormone receptor.</gtr:title><gtr:parentPublicationTitle>Molecular pharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/60fe7763581fe9d8ccb7b6d64afc8242"><gtr:id>60fe7763581fe9d8ccb7b6d64afc8242</gtr:id><gtr:otherNames>Stewart AJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0026-895X</gtr:issn><gtr:outcomeId>EAC3ADFA34F</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5A8D0F40-3DAC-4B2D-B611-9FF84DB162A0</gtr:id><gtr:title>GnRH-mediated DAN production regulates the transcription of the GnRH receptor in gonadotrope cells.</gtr:title><gtr:parentPublicationTitle>Neuromolecular medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cac938ec0dd9ea375263180f8739772e"><gtr:id>cac938ec0dd9ea375263180f8739772e</gtr:id><gtr:otherNames>L?pez de Maturana R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1535-1084</gtr:issn><gtr:outcomeId>1640FD5C4B2</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>772212B0-21CE-4450-8AE6-F7A77B93A631</gtr:id><gtr:title>Gonadotropin-releasing hormone receptor levels and cell context affect tumor cell responses to agonist in vitro and in vivo.</gtr:title><gtr:parentPublicationTitle>Cancer research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/de45de8bb44d401206ad3a7925ec7449"><gtr:id>de45de8bb44d401206ad3a7925ec7449</gtr:id><gtr:otherNames>Morgan K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0008-5472</gtr:issn><gtr:outcomeId>413D02D0DBA</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>51042C0F-E29D-4BA7-9BC8-40E6CBD3086D</gtr:id><gtr:title>Differential expression and functional characterization of luteinizing hormone receptor splice variants in human luteal cells: implications for luteolysis.</gtr:title><gtr:parentPublicationTitle>Endocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c28551404bc2b202da3d3e5fda1bb112"><gtr:id>c28551404bc2b202da3d3e5fda1bb112</gtr:id><gtr:otherNames>Dickinson RE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0013-7227</gtr:issn><gtr:outcomeId>506CD65A4C2</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B22892D8-8EB2-42CC-B86E-46BFCEBFFA33</gtr:id><gtr:title>Antiproliferative effects of GnRH agonists: prospects and problems for cancer therapy.</gtr:title><gtr:parentPublicationTitle>Neuroendocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0254dbc190faccb715829795816143ac"><gtr:id>0254dbc190faccb715829795816143ac</gtr:id><gtr:otherNames>White CD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0028-3835</gtr:issn><gtr:outcomeId>23C60A53AAC</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MC_U127681325</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>7C58A707-1BF6-4573-A44F-30B271C80813</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Cancer</gtr:text></gtr:healthCategory><gtr:healthCategory><gtr:id>FA7AA693-7EDD-4A7E-8CA3-6B5658FBF717</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Reproductive Health and Childbirth</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>8F896112-5A04-4A11-A9F0-2B446D9AAC8A</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>5.1  Pharmaceuticals</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>